This post is sponsored by Cervilenz Inc.
12.9 million babies are born too soon every year around the world, and 1 million of those babies die. The United States has the second-highest rate of prematurity in the world. Here, 1 of 8 babies is born prematurely, and these early deliveries are the leading cause of infant death and many long-term disability and health complications. It’s time to do more.
For more than a decade, researchers have been talking about cervical length as the best predictor of preterm birth risk. The shorter the cervix, the higher the risk. A big problem without a solution. Until now.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
This year, researchers are talking about an evidence-based intervention for prematurely short cervix. There is now conclusive data that vaginal progesterone treatment for women diagnosed with a short cervix mid-pregnancy reduces the rate of prematurity by 45% and improves infant outcomes. Diagnose a short cervix, and now we can treat it.
Today, leading Maternal-Fetal Medicine experts are calling for a fundamental shift in obstetrics practice to start measuring cervical length for all pregnant women to find high-risk patients for treatment.
Cervilenz Inc. — a small, venture capital-backed company — is poised to play a vital role. The company’s new CerviLenz® device gives doctors an immediate cervical length measurement during any prenatal visit.
While Americans are prone to look for high-tech solutions, sometimes the best answer is something simple. That’s what CerviLenz is — a simple, low-cost device that identifies pregnant women with a prematurely short cervix.
Prematurity is a $26.2 billion problem in the U.S. annually. When more moms have healthier babies, we save millions of dollars. Improving care while reducing cost. Today is a new day in the world of prematurity.
Learn more at www.measure2besure.com.
